These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38634891)

  • 1. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
    Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
    Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Wang YS; Zhou YL; Bai GN; Li SX; Xu D; Chen LN; Chen X; Dong XY; Fu HM; Fu Z; Hao CL; Hong JG; Liu EM; Liu HM; Lu XX; Luo ZX; Tang LF; Tian M; Yin Y; Zhang XB; Zhang JH; Zhang HL; Zhao DY; Zhao SY; Zhu GH; Zou YX; Lu Q; Zhang YY; Chen ZM
    World J Pediatr; 2024 Sep; 20(9):901-914. PubMed ID: 39143259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
    Tsai TA; Tsai CK; Kuo KC; Yu HR
    J Microbiol Immunol Infect; 2021 Aug; 54(4):557-565. PubMed ID: 33268306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Lee H; Yun KW; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
    Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
    J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
    Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
    BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
    Lung DC; Yip EK; Lam DS; Que TL
    Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
    Lung DC; Chan YH; Kwong L; Que TL
    Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levofloxacin on macrolide-unresponsive and corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children.
    Lin M; Shi L; Huang A; Liang D; Ge L; Jin Y
    Ann Palliat Med; 2019 Nov; 8(5):632-639. PubMed ID: 31865723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region.
    Chih-Cheng Lai ; Hsueh CC; Hsu CK; Tsai YW; Hsueh PR
    Int J Antimicrob Agents; 2024 Aug; 64(2):107205. PubMed ID: 38754527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis.
    Song X; Zhou N; Lu S; Gu C; Qiao X
    BMC Infect Dis; 2024 Oct; 24(1):1166. PubMed ID: 39407159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study.
    Meyer Sauteur PM; Seiler M; Tilen R; Osuna E; von Wantoch M; Sidorov S; Aebi C; Agyeman P; Barbey F; Bielicki JA; Coulon L; Deubzer B; Donas A; Heininger U; Keitel K; Köhler H; Kottanattu L; Lauener R; Niederer-Loher A; Posfay-Barbe KM; Tomaske M; Wagner N; Zimmermann P; Zucol F; von Felten S; Berger C
    Trials; 2024 Oct; 25(1):655. PubMed ID: 39363201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
    Morozumi M; Takahashi T; Ubukata K
    J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.